SCHEMBL25910813

SCHEMBL25910813

CNc1ncc(-c2ccc3cc(Oc4ccnc(N)c4Cl)ccc3n2)c(=O)n1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 3/20 0.41
▸ LCK P06239 3/20 0.41
▸ FLT3 P36888 3/20 0.41
▸ PDGFRB P09619 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ KIT P10721 2/20 0.41
▸ PDGFRA P16234 2/20 0.41
▸ PTK6 Q13882 1/20 0.41
▸ MET P08581 16/20 0.34
▸ KDR P35968 8/20 0.34
▸ MST1R Q04912 4/20 0.34
▸ AURKA O14965 1/20 0.34
▸ RPS6KA5 O75582 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ HGF P14210 1/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ MAPK9 P45984 1/20 0.34
▸ TEK Q02763 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ AXL P30530 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25910033 0.91 CSF1R (0.51) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25914570 0.91 CSF1R (0.42) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25910692 0.91 CSF1R (0.40) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25910908 0.90 CSF1R (0.41) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25910802 0.88 CSF1R (0.40) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25910918 0.86 CSF1R (0.35) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25914717 0.84 CSF1R (0.42) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25912165 0.82 CSF1R (0.53) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25910161 0.81 CSF1R (0.51) CSF1RLCKFLT3PDGFRBCYP2C9
SCHEMBL25910688 0.80 CSF1R (0.40) CSF1RLCKFLT3PDGFRBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback